Global Tech News Palestine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech News Palestine.

Press releases published on March 16, 2026

Mar. 16, 2026

SAIC Announces Fourth Quarter and Full Fiscal Year 2026 Results

Indeterminate GlobeNewswire

Mar. 16, 2026

CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 16, 2026

VivoPower Announces Effectiveness of New Stock Ticker “VIVO” and Corporate Name Change

Indeterminate GlobeNewswire

Mar. 16, 2026

Clarios Appoints Chris Courts as Chief Legal Officer

Indeterminate GlobeNewswire

Mar. 16, 2026

Bloomway AI Announces Public Beta of CinePro: Infusing Cinematic Expertise into AIGC to Redefine the "Lean Cinema" Workflow

Indeterminate GlobeNewswire

Mar. 16, 2026

Cronos Group Inc. to Speak at the 38th Annual ROTH Conference

Indeterminate GlobeNewswire

Mar. 16, 2026

nCino Launches Doc VOI to Help Lenders Automate Document-based Income Verification

Indeterminate GlobeNewswire

Mar. 16, 2026

Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026

Indeterminate GlobeNewswire

Mar. 16, 2026

MediciNova to Participate at the 38th Annual ROTH Conference

Indeterminate GlobeNewswire

Mar. 16, 2026

Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics

Indeterminate GlobeNewswire

Mar. 16, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 16, 2026

Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Indeterminate GlobeNewswire

Mar. 16, 2026

Tilray Brands Enters Agreement to Acquire BrewDog’s Key U.S. Assets, Expanding Its U.S. Craft Beer Platform

Indeterminate GlobeNewswire

Mar. 16, 2026

GigaCloud Technology Inc to Participate in 38th Annual Roth Conference

Indeterminate GlobeNewswire

Mar. 16, 2026

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine

Indeterminate GlobeNewswire

Mar. 16, 2026

Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Mar. 16, 2026

Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026

Indeterminate GlobeNewswire

Mar. 16, 2026

Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Indeterminate GlobeNewswire

Mar. 16, 2026

CytomX’s Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer

Indeterminate GlobeNewswire

Mar. 16, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

Indeterminate GlobeNewswire